Literature DB >> 7616355

Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas.

T Arai1, I Kino.   

Abstract

To estimate the effect of cell proliferation and deletion on the growth of the human colorectal adenoma, 27 tubular adenomas and eight villous adenomas were examined. Tubular adenomas were categorized into three grades of cellular atypia: mild, moderate, and severe. Villous adenomas were given a single grade. Morphological characteristics of apoptosis (nuclear condensation and budding) were used to quantify an apoptotic index, AI (percentage of apoptotic cells in viable adenomatous cells). The apoptotic cells were found mainly among the basal site of the adenomatous tubules. The AIs of tubular adenomas with mild, moderate, and severe grades of atypia were 3.5, 5.7 and 8.8 per cent, respectively. The AI of villous adenomas was 1.8 per cent, which was significantly lower than that of tubular adenomas. The mitotic indices, MIs (percentage of mitotic cells in viable adenomatous cells) of tubular adenomas were 0.41 per cent (mild), 0.58 per cent (moderate), and 0.83 per cent (severe), and for villous adenomas the MI was 0.38 per cent. There was a close positive relationship between the AI and MI of tubular adenomas, which paralleled the grade of atypia. These results indicate that both cell proliferation and death were more frequent in adenomas with severe atypia than in adenomas with mild atypia. Moreover, the significantly lower AI of villous adenomas, known to develop into large tumours when compared with tubular adenomas, suggests that reduced apoptoses may lead to a shift in tissue kinetics towards expansive growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616355     DOI: 10.1002/path.1711760107

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma.

Authors:  Y Shoji; M Saegusa; Y Takano; M Ohbu; I Okayasu
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

2.  Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.

Authors:  M Anti; A Armuzzi; S Morini; E Iascone; G Pignataro; C Coco; R Lorenzetti; M Paolucci; M Covino; A Gasbarrini; F Vecchio; G Gasbarrini
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 3.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

4.  Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling.

Authors:  M Ishida; Y Gomyo; S Tatebe; S Ohfuji; H Ito
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

5.  Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling.

Authors:  S F Moss; J V Scholes; P R Holt
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

6.  Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo.

Authors:  Jin-Ping Lai; Dalbir S Sandhu; Catherine D Moser; Sophie C Cazanave; Abdul M Oseini; Abdirashid M Shire; Viji Shridhar; Schuyler O Sanderson; Lewis R Roberts
Journal:  J Hepatol       Date:  2009-03-09       Impact factor: 25.083

7.  Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer.

Authors:  Alexandros D Polydorides; Bhramar Mukherjee; Stephen B Gruber; Barbara J McKenna; Henry D Appelman; Joel K Greenson
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

8.  Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas.

Authors:  Temitope O Keku; Ahmad Amin; Joseph Galanko; Christopher Martin; Barbara Schliebe; Robert S Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

9.  IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.

Authors:  Daniela Diehl; Doris Oesterle; Martin W Elmlinger; Andreas Hoeflich; Eckhard Wolf; Harald Lahm
Journal:  J Carcinog       Date:  2006-11-21

10.  Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study.

Authors:  Y Koshida; M Saegusa; I Okayasu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.